Brief: Cue Health Says It Received A Warning Letter From FDA About Its Emergency Use Authorized Covid-19 Test.
May 13 (Reuters) - Cue Health Inc HLTH.O :
* RECEIVED A WARNING LETTER FROM FDA ABOUT ITS EMERGENCY USE
AUTHORIZED (EUA) COVID-19 TEST.
* COMPANY IS CURRENTLY EVALUATING LETTER AND DETERMINING ITS
RESPONSE, WITH MORE INFORMATION TO FOLLOW IN NEXT FEW DAYS.
Source text for Eikon: ID:nBw4nllVLa
Further company coverage: HLTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Health
See all newsNASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
U.S. STOCKS ON THE MOVE-Salesforce, Birkenstock, Kohls Corp
U.S. STOCKS ON THE MOVE-Marathon Oil, Faraday Future, Semler Scientific
Brief: Cue Health Inc On May 16, Terminated Its Loan And Security Agreement, Dated June 30, 2022